Core Insights - The National Healthcare Security Administration (NHSA) is shifting its project establishment guidelines from a focus on technical details to a value-based approach centered on service output [2][3] Group 1: Project Establishment Guidelines - As of now, the NHSA has issued 33 batches of project establishment guidelines, integrating 1,640 main projects, 599 additional items, and 156 expansion items [3] - The new guidelines aim to standardize pricing projects across regions, addressing inconsistencies and ensuring comparability in pricing levels [3] - The guidelines emphasize a shift in project establishment logic from operational details to service output, reflecting the principle that "value determines price" [3] Group 2: Focus on Aesthetic Medicine - The new guidelines have unified 101 main projects in aesthetic medicine at the national level, covering procedures like "photorejuvenation," "ultrasound therapy," and "Thermage" [4] - The NHSA emphasizes that while the guidelines standardize projects, the pricing in the aesthetic medicine market will still be determined by medical institutions independently [4] Group 3: Integration of Services - The NHSA is integrating various projects to ensure a unified approach across the country, such as standardizing the "fetal heart monitoring" project to "fetal/instance" [5] - The integration process has reduced 271 existing projects to 124 main projects, allowing for a more granular approach that is more accommodating to new technologies [5] - Local healthcare departments are actively implementing the new guidelines, with provinces like Henan consolidating 54 rehabilitation projects into 17 [5] Group 4: Pricing Clarity and Support for Innovation - The new guidelines are making medical pricing clearer and more aligned with the value of technical services, as seen in Guangdong's reduction of 208 body system projects to 53 [6] - The guidelines have established pricing rules for anesthesia recovery phases, extending service periods to enhance patient safety [6] - The NHSA plans to accelerate the development of guidelines for pharmacy, testing, and auxiliary operations, aiming for comprehensive implementation by 2026 [6]